NCT04198961 is a NA clinical trial of opioid prescribing in Chronic Opioid Therapy, sponsored by Stanford University.

Who is sponsoring NCT04198961?

NCT04198961 is sponsored by Stanford University.

What drugs are being tested in NCT04198961?

Interventions in NCT04198961: opioid prescribing.

What condition does NCT04198961 study?

NCT04198961 studies Chronic Opioid Therapy.

Is NCT04198961 still recruiting?

NCT04198961 is currently completed. Last updated 9 November 2021.

Last reviewed 2021-11-09 · How we verify

NCT04198961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electronic Intervention to Chronic Opioid Therapy

Completed NA Last updated 9 November 2021

What this trial tests

NA trial testing opioid prescribing in Chronic Opioid Therapy in 43 participants. Completed in 17 June 2021.

Timeline

17 June 2020

Primary endpoint
17 June 2021

17 June 2021

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	43
Start date	17 June 2020
Primary completion	17 June 2021
Estimated completion	17 June 2021
Sites	1 location across United States

Drugs / interventions tested

opioid prescribing

Conditions studied

Chronic Opioid Therapy — all drugs for Chronic Opioid Therapy →

Sponsor

Stanford University

Who can join

Adults 18 to 65, any sex, with Chronic Opioid Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04198961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 9 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04198961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing